Insuline Medical Ltd
Yaad Sihan Projects Management and Entrepreneurship Ltd. is headquartered in Jerusalem, Israel.
Insuline Medical Ltd (INSL) - Total Assets
Latest total assets as of December 2017: ILA1.58 Million ILA
Based on the latest financial reports, Insuline Medical Ltd (INSL) holds total assets worth ILA1.58 Million ILA as of December 2017.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Insuline Medical Ltd - Total Assets Trend (2013–2017)
This chart illustrates how Insuline Medical Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Insuline Medical Ltd - Asset Composition Analysis
Current Asset Composition (December 2017)
Insuline Medical Ltd's total assets of ILA1.58 Million consist of 97.0% current assets and 3.0% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 72.6% |
| Accounts Receivable | ILA298.00K | 18.9% |
| Inventory | ILA0.00 | 0.0% |
| Property, Plant & Equipment | ILA47.00K | 3.0% |
| Intangible Assets | ILA0.00 | 0.0% |
| Goodwill | ILA0.00 | 0.0% |
Asset Composition Trend (2013–2017)
This chart illustrates how Insuline Medical Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Insuline Medical Ltd's current assets represent 97.0% of total assets in 2017, an increase from 74.1% in 2013.
- Cash Position: Cash and equivalents constituted 72.6% of total assets in 2017, up from 17.3% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2013.
- Asset Diversification: The largest asset category is accounts receivable at 18.9% of total assets.
Insuline Medical Ltd Competitors by Total Assets
Key competitors of Insuline Medical Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
XIWANG SPECIAL STEE (2XI.SG)
STU:2XI
|
Germany | €15.07 Billion |
|
LINDT & SPRUENGLI N - Dusseldorf Stock Exchang
DU:LSPN
|
Germany | €7.86 Billion |
|
PRICELINE.COM
BE:PCE1
|
Germany | €27.98 Billion |
|
PRICELINE GROUP (PCE1.SG)
STU:PCE1
|
Germany | €27.98 Billion |
|
MURPHY USA
BE:1MU
|
Germany | €4.40 Billion |
|
RESMED (RME.SG)
STU:RME
|
Germany | €7.22 Billion |
|
DIOS EXPLORATIONS
BE:BFM
|
Germany | €7.25 Million |
|
CHINA YUCHAI INTL (CYD.SG)
STU:CYD
|
Germany | €25.76 Billion |
Insuline Medical Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Insuline Medical Ltd generates 0.03x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Insuline Medical Ltd is currently not profitable relative to its asset base.
Insuline Medical Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.98 | 0.84 | 1.03 |
| Quick Ratio | 0.98 | 0.84 | 1.03 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA-39.00K | ILA -1.49 Million | ILA 282.00K |
Insuline Medical Ltd - Advanced Valuation Insights
This section examines the relationship between Insuline Medical Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -79.4% |
| Total Assets | ILA1.58 Million |
| Market Capitalization | $7.11K USD |
Valuation Analysis
Below Book Valuation: The market values Insuline Medical Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Insuline Medical Ltd's assets decreased by 79.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Insuline Medical Ltd (2013–2017)
The table below shows the annual total assets of Insuline Medical Ltd from 2013 to 2017.
| Year | Total Assets | Change |
|---|---|---|
| 2017-12-31 | ILA1.58 Million | -79.38% |
| 2016-12-31 | ILA7.66 Million | -9.92% |
| 2015-12-31 | ILA8.51 Million | -38.55% |
| 2014-12-31 | ILA13.85 Million | +36.34% |
| 2013-12-31 | ILA10.15 Million | -- |